Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant-Reference-Cited by-同舟云学术

Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant

Published:2006 Issue:5 Volume:98 Page:1037-1043
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Loukinov Dmitri,Ghochikyan Anahit,Mkrtichyan Mikayel,Ichim Thomas E.,Lobanenkov Victor V.,Cribbs David H.,Agadjanyan Michael G.

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcb.20953/fullpdf

Reference31 articles.

1. HLA AND CANCER: IMPLICATIONS FOR CANCER IMMUNOTHERAPY AND VACCINATION

2. Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

3. Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease

4. , , , , , , . 2006. The epigenetically acting tumor promoting transcription factor BORIS is a widely expressed tumor-associated antigen recognized by CD8+ cytotoxic lymphocytes (submitted).

5. Reciprocal Binding of CTCF and BORIS to the NY-ESO-1 Promoter Coincides with Derepression of this Cancer-Testis Gene in Lung Cancer Cells

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors;International Journal of Molecular Sciences;2023-03-22

2. The function of brother of the regulator of imprinted sites in cancer development;Cancer Gene Therapy;2022-11-14

3. Establishment and evaluation of cell and animal models expressing BORIS subfamily 2 variant;Annals of Translational Medicine;2022-06

4. Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model;Scientific Reports;2021-11-30

5. Immunization using male germ cells and gametes as rich sources of cancer/testis antigens for inhibition of 4T1 breast tumors' growth and metastasis in BALB/c mice;International Immunopharmacology;2019-09